Answer
Mar 27, 2025 - 02:08 PM
Olanzapine, an atypical antipsychotic, is commonly associated with metabolic side effects, which can be particularly problematic. These include significant weight gain, increased blood sugar levels, and dyslipidemia, contributing to an elevated risk of diabetes and cardiovascular issues. Monitoring and managing these metabolic changes are crucial when patients are on olanzapine therapy.
